Mechanisms and Consequences of Tau Internalization and Aggregation in the Central Nervous System

中枢神经系统 Tau 内化和聚集的机制和后果

基本信息

批准号：
10459632
负责人：
Jennifer Nicole Rauch
金额：
$ 24.32万
依托单位：
UNIVERSITY OF MASSACHUSETTS AMHERST
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-02-01 至 2024-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10459632
关键词：
Affect Age Aging Alzheimer&apos s Disease Area Astrocytes Biochemistry Brain Brain region CRISPR interference CRISPR-mediated transcriptional activation Cells Cellular Assay Cellular biology Clinical Critical Pathways Data Dementia Disease Disease Marker Disease Progression Gene Targeting Genes Genetic Transcription Homeostasis Human Human Genome Immune Immunologics Knowledge Learning Link Liquid substance Maintenance Mediating Memory Mentors Methodology Methods Microglia Molecular Neuraxis Neurodegenerative Disorders Neurofibrillary Tangles Neuroglia Neuroimmune Neurons Pathogenesis Pathologic Pathology Pathway interactions Pattern Phase Phenotype Play Process Regulation Research Resolution Role Severities Severity of illness Stress Symptoms System Tauopathies Technology Testing Work cell type experimental study functional genomics gene function in vivo induced pluripotent stem cell insight mouse model neuroinflammation novel novel therapeutic intervention physical state prevent protein aggregation receptor response screening single cell sequencing single-cell RNA sequencing tau Proteins tau aggregation tau mutation uptake

项目摘要

The aggregation of the protein tau occurs in a range of neurodegenerative diseases, including Alzheimer’s Disease1. The presence of tau aggregates, also known as neurofibrillary tangles (NFTs), is correlated with disease symptoms and clinical severity in patients2. In addition to tau pathology, the ability of innate immune cells in the brain, particularly microglia and astrocytes, to mediate neuroinflammation has been implicated as a significant contributor to Alzheimer’s Disease pathogenesis. Unfortunately, a detailed understanding of how tau aggregation is spurred in the central nervous system (CNS) and how this influences neuroimmune pathways has remained unclear. In the completed K99 phase, we discovered a cellular receptor for tau uptake, LRP1, and developed expertise in single-cell RNA sequencing methods. In the R00 phase, we will expand on the knowledge gained in the K99 mentored phase and focus the research on questions related to microglial tau regulation and cellular influences on tau’s physical state. In the first half of this proposal we will examine the molecular pathways that define microglial recognition of tau and decipher which genes are most critical for this process. In the second half we will leverage our functional genomics expertise to understand pathways critical for de novo aggregation of tau. The novel experimental methods and comprehensive analyses outlined herein will develop our understanding of pathogenic tau regulation. Further, with this mechanistic insight we will be able to envision novel therapeutic strategies for diseases such as Alzheimer’s Disease. Mandelkow, E. M. & Mandelkow, E. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2, a006247, doi:10.1101/cshperspect.a006247 (2012). Haroutunian, V., Davies, P., Vianna, C., Buxbaum, J. D. & Purohit, D. P. Tau protein abnormalities associated with the progression of alzheimer disease type dementia. Neurobiol Aging 28, 1-7, doi:10.1016/j.neurobiolaging.2005.11.001 (2007).

tau 蛋白聚集发生在一系列神经退行性疾病中，包括阿尔茨海默病1。tau 蛋白聚集体（也称为神经原纤维缠结 (NFT)）的存在与患者的疾病症状和临床严重程度相关2。大脑中的先天免疫细胞，特别是小胶质细胞和星形胶质细胞，介导神经炎症的能力被认为是导致阿尔茨海默病的重要因素不幸的是，对于 tau 蛋白聚集如何在中枢神经系统 (CNS) 中被刺激以及它如何影响神经免疫通路的详细了解仍不清楚。在完成的 K99 阶段，我们发现了 tau 蛋白摄取的细胞受体 LRP1，并开发了这种受体。在 R00 阶段，我们将扩展在 K99 指导阶段获得的知识，并将研究重点放在与小胶质细胞 tau 调节和细胞影响相关的问题上。在本提案的前半部分，我们将研究定义 tau 的小胶质细胞识别的分子途径，并破译哪些基因对此过程最关键。在后半部分，我们将利用我们的功能基因组学专业知识来了解对这一过程至关重要的途径。本文中的新颖实验方法和全面概述的分析将加深我们对致病性 tau 调控的理解。此外，通过这种机制洞察，我们将能够设想针对阿尔茨海默病等疾病的新治疗策略。疾病。 Mandelkow, E. M. 和 Mandelkow, E. 神经原纤维变性中 tau 蛋白的生物化学和细胞生物学，冷泉 Harb Perspect Med 2，a006247，doi：10.1101/cshperspect.a006247（2012）。 Haroutunian, V.、Davies, P.、Vianna, C.、Buxbaum, J. D. 和 Purohit, D. P. Tau 蛋白异常与阿尔茨海默病型痴呆的进展相关 28, 1-7, doi:10.1016/j.neurobiolaging。 .2005.11.001 (2007)。